Medicenna Therapeutics Corp.

De la TradeVille.ro wiki
Versiunea din 18 septembrie 2024 20:11, autor: Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Medicenna Therapeutics Corp. listata cu simbolul US.MDNA ==Descriere companie== Medicenna Therapeutics Corp. (https://www.medicenna.com) is a clinical stage immunotherapy company. The Company is primarily engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its Bi-functional...)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei Medicenna Therapeutics Corp. listata cu simbolul US.MDNA

Descriere companie[edit | ]

Medicenna Therapeutics Corp. (https://www.medicenna.com) is a clinical stage immunotherapy company. The Company is primarily engaged in the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its Bi-functional SuperKine ImmunoTherapies (BiSKITs) platform is designed to enable the ability of Superkines to treat immunologically cold tumors. The Company’s product candidate MDNA55, is an Empowered Superkine developed as a therapeutic for recurrent glioblastoma multiforme (rGBM), a fatal form of brain cancer. MDNA11, an IL-2 Superkine that has been fused with human recombinant albumin. The Company has not earned any revenues from its products.

Grafic actiuni companie[edit | ]

Ultimele stiri despre Medicenna Therapeutics Corp. (US.MDNA)[edit | ]

Adus de la „https://wiki.tradeville.ro/index.php?title=Medicenna_Therapeutics_Corp.&oldid=429879”